Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.01% | 137.62 | 0.0% | $902.91m | |
| AMGN | Amgen, Inc. | 0.62% | 249.04 | 1.5% | $834.11m | |
| GILD | Gilead Sciences, Inc. | -0.28% | 63.66 | 1.0% | $540.48m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.77% | 268.35 | 1.9% | $479.39m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.14% | 681.91 | 2.6% | $435.36m | |
| ILMN | Illumina, Inc. | 0.65% | 245.07 | 3.3% | $315.83m | |
| NVAX | Novavax, Inc. | -3.78% | 51.40 | 75.7% | $295.88m | |
| BIIB | Biogen, Inc. | -0.13% | 199.40 | 1.8% | $239.75m | |
| BNTX | BioNTech SE | 0.14% | 163.22 | 0.0% | $226.72m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.47% | 2.10 | 0.7% | $146.80m | |
| EXAS | EXACT Sciences Corp. | -2.20% | 52.00 | 17.7% | $143.85m | |
| TXG | 10X Genomics, Inc. | -0.80% | 49.76 | 0.0% | $100.48m | |
| TECH | Bio-Techne Corp. | -0.50% | 364.51 | 4.5% | $100.29m | |
| NKTX | Nkarta, Inc. | 0.79% | 12.77 | 0.0% | $100.05m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.80% | 80.36 | 4.2% | $99.19m |
Company Profile
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.